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Abstract
There is compelling in vivo evidence from reports on human genetic mutations and transgenic mice that some microRNAs
(miRNAs) play an important functional role in regulating skeletal development and growth. A number of published in vitro
studies also point toward a role for miRNAs in controlling chondrocyte gene expression and differentiation. However,
information on miRNAs that may regulate a specific phase of chondrocyte differentiation (i.e. production of progenitor,
differentiated or hypertrophic chondrocytes) is lacking. To attempt to bridge this knowledge gap, we have investigated
miRNA expression patterns in human embryonic cartilage tissue. Specifically, a developmental time point was selected, prior
to endochondral ossification in the embryonic limb, to permit analysis of three distinct populations of chondrocytes. The
location of chondroprogenitor cells, differentiated chondrocytes and hypertrophic chondrocytes in gestational day 54–56
human embryonic limb tissue sections was confirmed both histologically and by specific collagen expression patterns. Laser
capture microdissection was utilized to separate the three chondrocyte populations and a miRNA profiling study was
carried out using TaqManH OpenArrayH Human MicroRNA Panels (Applied BiosystemsH). Here we report on abundantly
expressed miRNAs in human embryonic cartilage tissue and, more importantly, we have identified miRNAs that are
significantly differentially expressed between precursor, differentiated and hypertrophic chondrocytes by 2-fold or more.
Some of the miRNAs identified in this study have been described in other aspects of cartilage or bone biology, while others
have not yet been reported in chondrocytes. Finally, a bioinformatics approach was applied to begin to decipher
developmental cellular pathways that may be regulated by groups of differentially expressed miRNAs during distinct stages
of chondrogenesis. Data obtained from this work will serve as an important resource of information for the field of cartilage
biology and will enhance our understanding of miRNA-driven mechanisms regulating cartilage and endochondral bone
development, regeneration and repair.
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Introduction
Development of cartilage tissue begins by the condensation of
mesenchymal stem cells (MSCs) and subsequent differentiation of
these cells toward the chondrocyte lineage. Cells within the
cartilage anlagen proliferate and generate an extracellular matrix
(ECM) rich in type II collagen and proteoglycans, thus permitting
cartilage growth and subsequent limb formation [1]. Cartilage of
the growth plate serves as a template for long bone formation
whereby proliferating chondrocytes terminally differentiate to
become large hypertrophic cells that specifically synthesize type X
collagen. Preceding apoptotic cell death, hypertrophic chondro-
cytes regulate matrix mineralization and blood vessel invasion
resulting in cancellous bone formation by a process known as
endochondral ossification [2]. Articular cartilage is found at the
bone epiphyses lining our joints and functions to lubricate and
distribute load within the joint. This hyaline cartilage is distinct
from growth plate cartilage in that chondrocytes do not terminally
differentiate toward hypertrophy and the mature tissue remains
avascular [3–5]. Many genes encoding a wide range of molecules
such as histone modifying proteins, transcription factors, growth
factors, ECM components, ECM modifying enzymes, cell
receptors etc are known to regulate specific stages of chondrocyte
differentiation. Mutations in or ablation of such cartilage-
regulatory genes are known to cause skeletal abnormalities,
resulting in diseases such as chondrodysplasias (growth plate
cartilage defects) or osteoarthritis (articular cartilage defects).
It has been estimated that as many as 60% of coding genes are
regulated by the family of small, non-coding RNAs called
microRNAs (miRNAs) [6]. This introduces another level of
complexity into the mechanisms that control cellular functions
for proper development of tissues and organs of the body,
including those of the skeletal system. With respect to miRNA
biogenesis, large primary (pri) miRNAs are first transcribed from
intergenic regions of the genome, or from introns of coding genes,
and then processed in the nucleus by a Drosha-containing protein
complex to smaller, 70–100 nucleotide (nt) precursor (pre)
miRNAs. Pre-miRNAs are transported from the nucleus to the
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cytoplasm by Exportin 5 and then further processed by another
protein complex containing the enzyme Dicer to generate small
(,19–24 nt) imperfect double-stranded miRNA duplexes. These
miRNA duplexes enter the RNA induced silencing complex
(RISC) containing important proteins called Argonautes that guide
interaction of either the 5p or 3p miRNA strand with its target
mRNA sequence [7]. These target sequences are commonly
located in 39UTRs but there are increased reports that miRNAs
can also bind to sequences within exons [8]. The overall effect of
these miRNA-target gene interactions is to down-regulate protein
expression via translational repression or mRNA degradation
[9,10].
Since their discovery in C. elegans in 1993, we now understand a
lot about the physiological roles of miRNAs in the mammalian
system with respect to controlling cell proliferation, lineage
determination, differentiation, apoptosis, etc [11,12]. Dysregula-
tion of miRNAs has been associated with a number of disease
states including cancers, cardiomyopathies, neurological disorders
and deafness [13–17]. However, there are only a few reports of
genetic mutations leading to skeletal defects in humans. One study
showed that germline deletion of the miR-17,92 cluster causes
human skeletal and growth defects involving microcephaly, short
stature and digital abnormalities [18]. A mutation in the 39UTR of
the human HDAC6 gene, which disrupts a miR-433 binding site,
was reported to cause a dominant X-linked chondrodysplasia [19].
Another report revealed a link between human juvenile osteopo-
rosis and a mutation in the precursor sequence of miR-2861 [20].
It is predicted that many more mutations will be reported as we
continue to learn about the functions of miRNAs in skeletal
biology [21–23].
To date, there is limited information on the expression and
function of specific miRNAs in cartilage development in vivo. What
is known, however, has predominantly come from studies in mice.
Conditional knock-out of the pre-miRNA processing enzyme,
Dicer, was shown to cause severe skeletal growth defects due to
alterations in chondrocyte proliferation and hypertrophy [24]. To
date, miR-140 is the best-described miRNA in cartilage since it
was identified as abundantly expressed and almost specific to
cartilaginous tissues during zebrafish and mouse development
[25,26]. miR-140 null mice have been generated by two
independent groups that reported craniofacial deformities and
dwarfism due to defects in growth plate cartilage of long bones
[27,28]. A role for miR-140 in regulating homeostasis of mature
articular cartilage has also been proposed [27]. In addition to
studies on miR-140, there is an increasing number of reports on
expression and function of other miRNAs in vitro. Among such
studies, attempts have been made to define miRNA expression
patterns and function during in vitro chondrogenesis of primary
stem cells or precursor cell lines [29–31]. Approaches have also
been applied to study miRNA expression in primary chondrocytes,
comparing differentiated vs de-differentiated cells or normal vs
osteoarthritic chondrocytes, for example [31–39]. While these
studies are important, they have not provided information on the
role of miRNAs in regulating specific phases of chondrocyte
differentiation in vivo during growth plate or articular cartilage
development, for example. To attempt to bridge this knowledge
gap, we investigated differential miRNA expression patterns
within human embryonic cartilage tissue. Specifically, we chose
a time point of development prior to endochondral bone
formation (gestational day 54–56) where three populations of
chondrocytes can be distinguished in tissue sections of the human
embryonic limb. Utilizing laser capture microdissection, cartilage
tissue containing either precursor chondrocytes, differentiated
chondrocytes or hypertrophic chondrocytes was isolated and
expression of miRNAs in each region was determined by
TaqManH OpenArrayH analysis. Here, we report on those
miRNAs that were found to be significantly differentially expressed
between chondrocytes in vivo at these three specific stages of
development. Data acquired from this study will be an important
resource of information toward a better understanding of miRNA
function in regulating cartilage and long bone development and
disease. Additionally, findings from this research may aid toward
the development of future miR-based tissue engineering strategies
to promote articular cartilage or endochondral bone repair or
regeneration.
Materials and Methods
Tissue source and ethics statement
Human, normal embryonic tissue samples (limbs) at gestational
day 54–56 were obtained from a tissue collection and distribution
program at the Laboratory of Developmental Biology (LDB)
within the Department of Pediatrics and Medicine at the
University of Washington in Seattle. This service provides
precisely-staged normal human embryonic tissue specimens to
grant-funded researchers nationally and internationally [40–42].
Activities of this Laboratory are IRB-approved by the University
of Washington Human Subjects Division (protocol # 41557).
These approved activities include the documentation of written
informed consent by the donor participants to collect tissue
following surgery and to distribute the tissue to researchers.
Funding for this tissue collection and distribution service is
currently provided from the National Institute of Child Health and
Human Development of the National Institutes of Health (R24
HD000836). Request to work with this human embryonic tissue
was reviewed by the Human Research Protection Office (HRPO)
at Washington University in St Louis. This project was deemed
exempt since it did not constitute human subjects research. This
was due to the fact that receiving embryonic tissue from University
of Washington would not involve obtaining data through
intervention or interaction with a living individual. Also, other
than gestational age, no identifying information was provided
upon receipt of the tissue. Limb tissues obtained by LDB Staff
were frozen immediately in coronal orientation in Tissue-TekH
O.C.T. compound and shipped overnight to the McAlinden
Laboratory. Tissue was stored at minus 80uC for no longer than 2
wk before collecting frozen sections. In some cases, tissue collected
by LDB Staff was immediately fixed in 10% formalin and shipped
to the McAlinden Laboratory within 24 h. Upon receipt, tissue
was processed immediately for paraffin embedding.
Histology and immunofluorescence
Paraffin sections were treated with xylene, rehydrated through
decreasing concentrations of ethanol, stained in Weigert’s
Hematoxylin for 5 min, washed in running water for 5 min and
stained with 0.001% Fast Green for 3 min. Samples were then
rinsed in 1% glacial acetic acid and stained in 0.1% Safranin O for
5 min. Samples were dehydrated and cleared by incubation in
95% alcohol, 100% alcohol and then xylene. For immunofluo-
rescent antibody (Ab) staining, de-paraffinized sections were
treated with 1% hyaluronidase (Sigma) for 30 min at 37uC.
Sections were rinsed with 16 PBS and blocked with 10% goat
serum for 1 h at room temperature and then incubated overnight
at 4uC with the following primary antibodies: 1) a rabbit
polyclonal ‘‘anti-IIA’’ antibody (Ab) that recognizes the exon 2-
encoded cysteine-rich domain of the amino propeptide of type II
procollagen (1/400 dilution) [43]; 2) a rat polyclonal Ab against
the triple helical domain of type II collagen (1/100 dilution) [44];
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3) a rabbit polyclonal Ab against type I collagen (1/300 dilution)
(abcamH); and 4) a rabbit polyclonal Ab against the hypertrophic
chondrocyte marker, type X collagen (1/1000 dilution) [45,46].
Each antibody was diluted in 2% goat serum. Following 16PBS
washes, paraffin sections were incubated with species-specific
secondary antibodies (1/250 dilution) that were conjugated to
Alexa fluorescent dyes (Invitrogen: goat anti-rabbit Alexa 488;
goat anti-rat Alexa 594) for 1 h at room temperature. DAPI
mounting medium was applied following three rinses in 16 PBS
and stained sections were cover-slipped. A Nikon Eclipse E800
fluorescence microscope was used to view the fluorescent images.
The FITC and TRITC band pass filter sets were used to view
sections labeled with Alexa 488 and 594 dyes, respectively and the
DAPI filter set was used for viewing cell nuclei.
Laser capture microdissection and RNA isolation
Frozen blocks of human embryonic limb tissue were sectioned
(20 mm) onto RNAse-free polyethylene naphthalate (PEN)-coated
glass slides (Leica Microsystems) that are specifically designed for
laser capture microdissection (LCM). Frozen sections were stored
at minus 80uC for up to 48 h before being processed for LCM.
Upon removal from cold storage, the tissue sections were exposed
to 30 s incubations in cold 75% ethanol followed by 50% ethanol,
20% ethanol, dH2O, 0.02% Toluidine Blue (prepared in RNAse
free H2O), two dH20 washes, 75% ethanol, 95% ethanol and
100% ethanol. Finally, sections were transferred to xylene for
3 min and air-dried. LCM was immediately carried out using the
LMD7000 system (Leica Microsystems). Three cartilage regions of
interest in each tissue section were selected using the system
software resulting in a contact and contamination-free collection of
tissue directly into one of the three sterile 0.5 mL Eppendorf caps
containing 60 ml of lysis buffer from the RNA isolation kit of
choice. This procedure was repeated for all tissue sections derived
from one limb specimen (generally 35–40 sections per limb) and
laser-captured tissue was pooled together into the appropriate
collection vial. In some cases, both limbs were obtained from the
same embryo and tissue collected from sections of each limb was
pooled and counted as one specimen. Subsequently, for each
specimen (whether one or two limbs were received), three separate
Eppendorf tubes containing tissue from the precursor chondrocyte
(PC), differentiated chondrocyte (DC) or hypertrophic chondro-
cyte (HYP) regions were obtained. Note than PC, DC or HYP
tissue was dissected from both the developing femur and tibia and
pooled together. A total of nine independent specimens were
processed for LCM. Total RNA, including small miRNAs, was
isolated from laser capture microdissected tissue using either the
Total RNA Purification Micro Kit (Norgen Biotek Corp.) or the
mirVanaTM miRNA Isolation Kit (AmbionH). Both assay kits were
comparable with respect to the RNA yield (ranging from 15–
100 ng/mL depending on the number of tissue sections pooled) as
measured by spectrophotometry (NanoDropTM; Thermo Scien-
tific).
TaqManH OpenArrayH technology to determine
microRNA expression profiles
The TaqManH OpenArrayH Human MicroRNA Panel enables
simultaneous running of hundreds of TaqManH MicroRNA
Assays in a plate format on the Applied Biosystems OpenArrayH
Real-Time PCR system [47]. To prepare samples for OpenArrayH
analysis, mature miRNAs in the RNA samples obtained by LCM
were reverse transcribed using MegaplexTM RT primers in a set of
two pre-defined pools (Pool A and Pool B), each pool containing
up to 381 stem-looped RT primers. Depending on the concen-
tration of RNA obtained from each specimen, 30 ng of RNA was
used for the RT step (lower than the recommended amount of
100 ng). The recommended RT thermal cycling conditions were
used: 16uC, 2 min; [42uC, 1 min; 50uC, 1 sec for 40 cycles]; 85uC,
5 min; 4uC hold. An aliquot of the RT reaction (5 mL instead of
the recommended 2.5 mL) was used for the non-biased pre-
amplification step to increase the quantity of cDNA prior to PCR
on the TaqManH OpenArrayH MicroRNA Panel. PreAmp
Reaction Mix, containing PreAmp Primer Pool A or Pool B and
TaqManH PreAmp Master Mix (20 mL) was added to RT cDNA
(5 mL) and the final 25 mL reaction mix underwent pre-amplifi-
cation using the following thermal cycling parameters: 95uC
10 min; 55uC, 2 min; 72uC, 2 min; [95uC, 15 sec, 60uC, 4 min for
15 cycles], 99.9uC, 10 min; 4uC hold. The number of cycles in this
pre-amplification step was increased from the recommended 12
cycles to 15 cycles. The pre-amplification products (5 mL) were
diluted in 0.1X TE buffer (95 mL) before adding the samples on
the TaqManH OpenArrayH MicroPanels (a 20 fold dilution
instead of the recommended 40 fold dilution of pre-amplified
cDNA products). Finally, trained staff at Washington University
Genome Technology Access Center loaded the diluted pre-
amplification samples onto the TaqManH OpenArrayH Micro-
RNA Panels using the AccuFillTM System and PCR was carried
out on the OpenArrayH Real-Time PCR System using the
manufacturer’s instructions. Note that the alterations in the
recommended protocol (i.e. reduced levels of RNA for the RT
step, increased pre-amplification cycle numbers and reduced
dilution of the pre-amplified cDNA samples) were made due to the
relatively low concentrations of RNA obtained from laser capture
microdissection. Importantly, technical staff at Life Technologies
(Dr. Yu Liang, personal communication) tested the feasibility of
using the adjusted protocol by analyzing human lung RNA
samples and comparing miRNA expression data generated from
the adjusted protocol and the recommended protocol. miRNA
expression profiles were found to correlate well between the
recommended and adjusted protocols (Figure S1).
Analysis of TaqManH OpenArrayH microRNA expression
data
Expression data were processed using OpenArrayH Real-Time
qPCR Analysis Software (BioTroveTM, version 1.0.4). This
software processed raw fluorescent signal and generated the cycle
threshold (Ct) and cycle threshold confidence value for each assay
within the array. A Ct confidence value threshold of 150 was used
to identify assays with a reliable Ct value. After this filtering, Ct
values were imported into the DataAssistTM software (Applied
Biosystems, version 2.7). The maximum allowable Ct value was set
at 29. This Ct cut-off was chosen since OpenArrayH reactions are
carried out in small volumes (33 nL); a single molecule is more
concentrated in a smaller reaction volume and amplifies sooner
than it would from regular microplate qPCRs. Personal commu-
nication with Life Technologies technicians informed us that single
copy numbers will produce, on average, a Ct value of 29 with
TaqManH assays. The correlation of Ct values between samples
from the same cartilage region was examined to identify any
samples with potential low data quality. For normalization using
an endogenous control, the stability scores chart was used to
identify which one of the three endogenous control RNAs
(RNU44, RNU48 or U6 rRNA) had the most stable expression
in multiple samples. For global normalization, the average of Ct
values for all the assays excluding the three endogenous controls
was calculated and this value was used as the background setting.
The Ct value of the selected background was subtracted from the
Ct value of each assay to calculate the DCt values. To identify
highest-expressed miRNAs, the average normalized expression
MicroRNAs in Human Embryonic Chondrocytes
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level of a miRNA from all samples was calculated (average 22DCt).
The same list of most highly-expressed miRNAs was generated
regardless of whether RNU44 or global mean normalization was
used. Therefore, data on differentially-expressed miRNAs was
calculated using RNU44 normalization. Using the normalized
DCt values, the fold change between two groups of samples
collected from two different cartilage regions was calculated as
mean (2(2DCt1
))/mean (2(2DCt2
)). Significance Analysis of Micro-
arrays (SAM) [48–51] was used to calculate the significance of
differential expression. miRNAs with at least a two fold change in
expression between cells of two cartilage regions, at a false
discovery rate less than or equal to 5% (q-value), were identified as
differentially expressed. Raw data has been submitted to the GEO
data depository (online at www.ncbi.nlm.nih.gov/geo/) and
assigned the accession code: GSE49152.
Pathway analysis of potential microRNA target genes
Following identification of miRNAs that are differentially-
expressed between the three cartilage regions (PC, DC and HYP),
potential target genes of miRNAs within each comparison group
were predicted using three algorithms (TargetScan, miRanda,
PicTar) [6,52,53]. For miRanda target prediction, target genes
were selected if they contained at least one binding site with an
mirSVR score#20.1. For TargetScan prediction, target genes
with at least one conserved miRNA binding site were selected.
Overall, for each miRNA in question, genes predicted to be targets
by at least two of the three algorithms were identified. This was
repeated for each miRNA listed in each comparison group: [i)
PC.DC; ii) PC,DC; iii) DC.HYP and iv) DC,HYP] and all
potential target genes were consolidated and entered into
MetaCoreTM (Thomson Reuters Systems Biology Solutions) to
characterize biological pathways involving these potential target
genes. Pathway maps were used in enrichment analysis and
significant pathways were identified using a hypergeometric p-
value cut-off of 0.05. This approach has been used in previous
studies to identify pathways underlying predicted targets of
miRNAs [54,55]. We did not include differentially expressed
miRNAs found in the PC vs HYP comparisons for these analyses
since many of the same miRNAs listed here were also found in the
other comparisons. Also PC and HYP cells are at extreme ends of
the differentiation spectrum. At this stage, we were initially
interested in identifying enriched pathways that may be regulated
by miRNAs through the normal course of differentiation (i.e. PC
PDC P HYP cells).
Results
Tissue selection for laser capture microdissection
Human embryonic limbs at day 54–56 of gestational develop-
ment were chosen for these studies to separate three specific
regions containing chondrocytes at distinct stages of differentia-
tion. Figure 1 shows a proteoglycan-stained (Safranin O) tissue
section of a gestational day 54 human limb focusing in on the
developing proximal tibia. Three regions are denoted that
predominantly contain: 1) precursor chondrocytes (PC) at the
most proximal end and at the perimeter within the surrounding
perichondrium; 2) differentiated chondrocytes (DC) within the
mid-region of the developing limb, some of which show an obvious
flattened phenotype; 3) enlarged hypertrophic chondrocytes (HYP)
that will eventually undergo programmed cell death by apoptosis.
This stage of development is just prior to vascular invasion of the
hypertrophic cartilage and subsequent endochondral ossification.
Collagen immunolocalization confirms the location of the PC
region by positive staining of the ‘‘embryonic’’ IIA procollagen
isoform (Figure 2A) and type I collagen (Figure 2B), two known
markers of chondroprogenitor cells. The ‘‘IIA’’ antibody recog-
nizes the conserved cysteine-rich protein domain encoded by
alternatively-spliced exon 2 of the COL2A1 gene [43]. Exon 2 is
present in mRNA generated by chondroprogenitor cells, whereas
differentiated chondrocytes generate mRNA devoid of exon 2
(encoding type IIB procollagen) [56,57]. Chondrocytes in a more
differentiated state do not express type IIA procollagen or type I
collagen. The presence of some IIA protein staining in the
hypertrophic zone (Figure 2A) has also been reported before in
human limb tissue at a similar time-point of development [58].
Type II collagen (i.e. the triple-helical domain of processed type II
procollagen) is present throughout the entire developing limb, as
expected (Figure 2C). Therefore, the DC region was selected
based on both cell phenotype (as seen by histology; Figure 1) and
by the presence of processed type II collagen and the absence of
type IIA and type I collagens (Figures 2A, B). Type X collagen is
a marker of hypertrophic chondrocytes and is localized to the
HYP region of the developing limb (Figure 2D).
Figure 1. Safranin-O-stained tissue section of a human
embryonic developing proximal tibia (gestational day 54).
Red-orange staining represents proteoglycans in the developing
cartilage extracellular matrix. This stage of development is prior to
endochondral ossification. Chondrocytes at various stages of differen-
tiation are present at this stage: precursor chondrocytes (PC) are found
at the most proximal end of the developing tibia as well as in the
surrounding perichondrium; differentiated chondrocytes (DC) are
located further down the developing limb and are distinguishable by
their cuboidal or flattened phenotype, depending on their location;
hypertrophic chondrocytes (HYP) are terminally-differentiated cells
easily distinguished by their increased size. Also shown in this image are
the developing femoral condyles (fc) of the distal femur. Scale
bar = 250 mm.
doi:10.1371/journal.pone.0075012.g001
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MicroRNA expression analysis
Laser capture microdissection of tissue sections from nine
independent limb specimens was successfully carried out as shown
in Figure 3. Note than an area between the PC and DC region
was not isolated by laser capture microdissection. It is expected
that this ‘‘grey area’’ contains a mixture of progenitor and
differentiated chondrocytes; inclusion of cells from this site would
likely dilute the data resulting in lower numbers of differentially-
expressed miRNAs identified between PC and DC regions. RNA
extracted from PC, DC and HYP areas was processed for analysis
on TaqManH OpenArrayH Human MicroRNA Panels and
expression of over 750 miRNAs was determined. One ‘‘PC’’
sample was discarded from further analysis for its low data
correlation with other PC samples. Table 1 lists the top thirty
most abundantly expressed miRNAs in chondrocytes from PC,
DC and HYP regions. Notably, miR-140-5p, the best-described
Figure 2. Immunofluorescence staining of different collagen types in a human developing embryonic proximal tibia (gestational
day 54). (A) Localization of the embryonic isoform of type II procollagen (type IIA) in the extracellular matrix (ECM). The anti-IIA antibody recognizes
the exon 2-encoded cysteine-rich domain present in the amino propeptide of type IIA procollagen [43]. These IIA isoforms are generated
predominantly by progenitor chondrocytes seen at the periphery and most proximal area of the developing tibia. Some expression of IIA procollagen
has been reported in the pre-hypertrophic and hypertrophic region of developing cartilage [58] and is also shown here. (B) Type I collagen staining is
restricted to the areas of precursor chondrocytes and cells of the perichondrium/periosteum. (C) Type II collagen staining patterns (i.e. the processed
triple helical domain of type II collagen) is present throughout the entire developing limb. (D) Collagen X staining is restricted to the ECM containing
hypertrophic chondrocytes. Cell nuclei are visualized in blue by DAPI staining. Scale bars = 100 mm. Immunofluorescent images are representative of
three independent experiments using gestational day 54 tissue sections from different embryos.
doi:10.1371/journal.pone.0075012.g002
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miRNA in cartilage to date, was found to be one of the most
highly expressed (albeit not differentially-expressed) miRNAs in all
three of the cartilage regions analyzed, thus providing additional
confidence in the array data.
Differentially-expressed microRNAs
From the OpenArrayH expression data, we identified miRNAs
that were differentially expressed by 2 fold or more between: 1) PC
and DC (Table 2); 2) PC and HYP (Table 3) and 3) DC and
HYP regions (Table 4). It is noteworthy that the number of
differentially-expressed miRNAs was greatest when comparing
cells between the PC and HYP regions (Table 3). This is not
surprising given the fact that precursor and hypertrophic
chondrocytes are at extreme ends of the differentiation spectrum.
Also, we did not identify any miRNAs that were exclusively
expressed in one region but absent from another region of human
embryonic developing cartilage. In many cases, the same miRNAs
were found to be differentially-expressed in more than one
comparison. Fewer miRNAs were identified as being significantly
more highly-expressed in DC or HYP chondrocytes when
compared to PC cells. For example, miRs-138, 193b and 365
were the only ones found to be expressed at higher levels in DC
compared to PC cells (Table 2). These miRNAs were also more
highly expressed in HYP cells when compared to PC cells,
suggesting function(s) in regulating gene pathways associated with
later stages of chondrogenesis. Those miRNAs that were
specifically more abundantly-expressed in HYP cells compared
to DC or PC cells suggests functional role(s) in regulating terminal
differentiation of chondrocytes and/or endochondral ossification
processes (Tables 3 and 4). As will be elaborated on in the
Discussion, a number of differentially-expressed miRNAs identi-
fied in this study have been described in other aspects of cartilage
biology and in other systems that may provide clues toward
identifying their function in regulating specific stages of chondro-
cyte differentiation. Importantly, this study has identified a
number of miRNAs that have not yet been reported to be
expressed in cartilage chondrocytes.
Pathway analysis of predicted microRNA target genes
Potential target genes were identified for each miRNA listed in
Tables 2 and 4 using defined criteria for target selection (i.e.
targets predicted by at least two of three chosen algorithms; see
Materials and Methods). All predicted target genes for miRNAs
differentially expressed between cells in the PC and DC region and
those differentially-expressed between cells of the DC and HYP
regions were entered into MetaCoreTM to identify cellular
pathways that are underlying these genes. Many significant
‘‘over-represented’’ pathways were identified for each comparison
[i) PC.DC; ii) PC,DC; iii) DC.HYP; iv) DC,HYP] including
those involved in cytoskeletal remodeling, cell cycle, transcription,
apoptosis etc. At this stage, we have focused only on developmen-
tal pathways that have relevance within the context of chondro-
genesis. Tables 5, 6, 7, 8 list the top 6–7 developmental
pathways that may be regulated by miRNA groups that we have
shown are more highly expressed within a specific region of
developing cartilage tissue. Enriched pathways common between
all comparisons include those related to growth factor signaling/
regulation that are known to be important at various stages of
chondrocyte differentiation (i.e. IGF-1, TGF-b, BMP, FGF
signaling pathways; Tables 5, 6, 7, 8). Interestingly, the majority
of enriched pathways of predicted genes targeted by miRNAs
more highly expressed in DC compared to PC cells were related to
Hedgehog and Wnt signaling pathways (Table 6). VEGF
signaling pathways were implicated to be regulated by miRNAs
Figure 3. Laser capture microdissection of a human embryonic tibia tissue section (gestational day 54). Left panel shows a processed
frozen tissue section and the right panel shows the same tissue section following laser capture microdissection to separate regions containing
precursor chondrocytes (PC), differentiated chondrocytes (DC) or hypertrophic chondrocytes (HYP). Also in view is cartilage tissue of the femoral
condyles (fc); the developing femur was also micro-dissected to separate the three regions of cartilage. Images were taken using the LMD7000 laser
capture microscope set at the 66 objective.
doi:10.1371/journal.pone.0075012.g003
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more highly expressed in PC cells (Table 5) or DC cells (Table 7).
Notably, the developmental pathway involving IL-8 in angiogen-
esis was specific to the group of miRNAs more highly expressed in
HYP cells compared to DC cells (Table 8). For a list of the genes
involved in each significantly-enriched pathway that were found to
be potential targets of miRNAs in each differentially-expressed
group, see Tables S1, S2, S3, S4.
Discussion
This novel study is the first to report on the in vivo expression
patterns of miRNAs in chondrocytes from human embryonic
cartilage tissue in the developing limb. The significance of this
work is further highlighted by the fact that three distinct regions of
the developing limb were separated by laser capture microdissec-
tion to permit analysis of miRNA expression in precursor
chondrocytes (PC), differentiated chondrocytes (DC) or hypertro-
phic chondrocytes (HYP) of the femur and tibia. While other
studies have been carried out to identify mRNA or miRNA
expression in chondrocytes from different sites of mouse or chicken
cartilage tissue, either late-stage embryonic, neonatal or post-natal
tissue was utilized [24,59,60]. The type of study described in this
report to determine miRNA expression in three distinct popula-
tions of chondrocytes at an early stage of human embryonic
development (day 54–56 of gestation; prior to primary endochon-
dral ossification) would be extremely challenging in mouse, rat or
chicken tissue due to size constraints. Given the many advantages
of using human embryonic tissue, it was not possible to confidently
delineate and isolate the small region containing pre-hypertrophic
chondrocytes in our system. We therefore expect that a proportion
of these cells were present in both the DC and HYP samples
following laser capture microdissection. Also, it is unclear at
present if data generated from this study will be useful toward
Table 1. Top 30 most abundantly expressed miRNAs in precursor, differentiated and hypertrophic chondrocytes
from gestational day 54–56 human embryonic cartilage tissue.
Precursor Chondrocytes (PC) Differentiated Chondrocytes (DC) Hypertrophic Chondrocytes (HYP)
miRNA Average(22DCt) miRNA Average(22DCt) miRNA Average(22DCt)
miR-140-5p 10.76 miR-140-5p 10.72 miR-24 6.66
miR-125b 6.84 miR-24 7.73 miR-92a 5.88
miR-19b 5.82 miR-19b 4.04 miR-140-5p 5.82
miR-30c 4.78 miR-376a 3.66 miR-19b 5.07
miR-199a-3p 4.39 miR-125b 3.38 miR-20a 4.08
miR-92a 3.69 miR-92a 3.25 miR-106a 3.40
miR-376a 3.25 miR-127 2.56 miR-127 3.06
miR-214 2.99 miR-409-3p 2.23 miR-193b 2.92
miR-26a 2.61 miR-30c 2.21 miR-212 2.85
miR-99b 2.53 miR-193b 2.09 miR-30c 2.54
miR-30b 2.40 miR-30b 1.94 miR-17 2.52
miR-382 2.37 miR-26a 1.87 miR-376a 2.33
miR-409-3p 2.21 miR-199a-3p 1.87 miR-125b 2.11
miR-106a 2.02 miR-20a 1.85 miR-30b 1.81
miR-130a 2.02 miR-214 1.67 miR-409-3p 1.60
miR-20a 1.75 miR-574-3p 1.66 miR-26a 1.40
miR-484 1.56 miR-106a 1.62 miR-214 1.39
miR-27b 1.46 miR-99b 1.36 miR-199a-3p 1.31
miR-127 1.45 miR-130a 1.29 miR-484 1.28
miR-331 1.39 miR-484 1.25 miR-181a-2 1.26
miR-206 1.36 miR-212 1.23 miR-206 1.15
miR-574-3p 1.33 miR-455-3p 1.19 miR-210 1.11
miR-455-3p 1.19 miR-206 1.05 miR-99b 1.06
miR-26b 1.17 miR-331 1.01 miR-331 1.06
miR-335 1.12 miR-370 1.00 miR-574-3p 1.00
miR-320 1.12 miR-210 0.82 miR-455-3p 0.90
miR-100 1.12 miR-17 0.80 miR-191 0.88
miR-23b 1.10 miR-27b 0.78 miR-133a 0.76
miR-210 0.97 miR-191 0.78 miR-320 0.72
miR-191 0.96 miR-410 0.73 miR-370 0.69
Highly expressed miRNAs were identified according to their average (2-DCt) values. Delta (D) Ct value for each miRNA was calculated by subtracting the Ct value of
endogenous control, RNU44, from the Ct value of the specific miRNA. Expression level average (22DCt) in a region reflects the average of 22DCt values across all samples
in that region.
doi:10.1371/journal.pone.0075012.t001
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understanding miRNA-regulated processes that form chondro-
cytes found in permanent articular cartilage since the exact
location/subset of precursor cells that form this tissue is not
entirely understood [61,62] and the time point of development
chosen for these studies may not be appropriate in this context.
Regardless of these issues, we have generated an important
database to begin to decipher miRNAs that may play a functional
role in regulating not only chondrogenesis, but also specific phases
of chondrocyte differentiation during limb development.
Highly expressed microRNAs
The miRNA expression database was obtained using Human
MicroRNA OpenArrayH Panels on the OpenArrayH Real-Time
PCR system [47]. Since this system determined miRNA expres-
sion based on TaqManH technology, further validation of
expression (as is required for hybridization-based microarrays)
was not necessary. From Table 1 that lists the top thirty most
highly-expressed miRNAs in PC, DC and HYP, miR-140-5p was
found to be one of the most abundant regardless of the status of
chondrocyte differentiation. This finding provides confidence in
the array data since miR-140 is the best-described miRNA in
Table 2. Differentially-expressed miRNAs between
precursor chondrocytes (PC) and differentiated
chondrocytes (DC) from gestational day 54–56 human
embryonic cartilage tissue.
PC compared to DC
PC.DC PC,DC
miRNA f.c. Score q-value miRNA f.c. Score q-value
miR-224 5.09 3.59 0 miR-138 -12.18 -3.29 2.09
miR-1247 4.59 4.21 0 miR-193b -3.63 -4.63 0
miR-335* 4.37 3.16 0 miR-365 -2.45 -3.45 0
miR-532 4.25 3.67 0
miR-146b 3.55 3.97 0
miR-24-2-5p 3.33 2.17 2.09
miR-660 3.32 3.17 0
miR-502-3p 3.23 2.68 0
miR-532-3p 3.16 3.61 0
miR-27a 2.99 2.86 0
miR-10b-3p 2.83 3.84 0
miR-708 2.75 1.87 3.16
miR-100 2.58 2.90 0
miR-29c 2.57 2.87 0
miR-199a-3p 2.35 2.95 0
miR-196b 2.30 3.22 0
miR-30d 2.18 1.90 3.16
miR-30c 2.16 2.24 2.09
miR-454 2.12 3.16 0
miR-151-5p 2.09 1.90 3.16
miR-323-3p 2.09 3.25 0
miR-335 2.09 2.31 0
miR-99b* 2.05 2.65 0
Fold change (f.c.) expression of miRNAs between cells of PC and DC regions are
shown. The score (d) and q-values for each differentially-expressed miRNA are
shown based on SAM analysis (FDR#5%; n = 8–9).
doi:10.1371/journal.pone.0075012.t002
Table 3. Differentially-expressed miRNAs between
precursor chondrocytes (PC) and hypertrophic
chondrocytes (HYP) from gestational day 54–56
human embryonic cartilage tissue.
PC compared to HYP
PC.HYP PC,HYP
miRNA f.c. Score q-value miRNA f.c. Score q-value
miR-335* 40.38 3.85 0 miR-181a-1 -17.36 -3.22 0.54
miR-532-5p 10.85 4.30 0 miR-138 -16.61 -3.50 0
miR-224 10.22 3.46 0 miR-193b -5.06 -6.24 0
miR-660 8.62 4.02 0 miR-150 -4.33 -2.07 4.42
miR-483-3p 8.19 12.88 0 miR-1291 -3.88 -2.41 3.92
miR-335 7.92 4.20 0 miR-193b* -3.75 -2.10 4.42
miR-532-3p 7.17 4.67 0 miR-181a-2 -3.26 -2.36 4.42
miR-146b 6.87 4.88 0 miR-1290 -2.98 -2.27 4.42
miR-502-3p 6.41 2.62 0 miR-202 -2.91 -1.99 4.42
miR-196b 5.30 5.20 0 miR-17 -2.75 -3.99 0
miR-125a-5p 5.24 3.21 0 miR-365 -2.74 -2.30 4.42
miR-93 4.65 1.76 0.94 miR-222 -2.70 -2.77 2.63
miR-301 4.26 3.20 0 miR-139-5p -2.57 -3.16 0.54
miR-323-3p 4.07 5.23 0 miR-20a -2.33 -2.73 2.63
miR-10b-3p 4.03 5.18 0 miR-126 -2.22 -1.96 4.42
miR-100 3.97 4.06 0 miR-127 -2.10 -2.56 3.92
miR-454 3.87 4.82 0
miR-151-5p 3.80 2.54 0
miR-16 3.65 4.00 0
miR-758 3.49 2.18 0.54
miR-93* 3.45 4.32 0
miR-199a-3p 3.36 3.80 0
miR-320b 3.34 3.24 0
miR-130a 3.28 2.78 0
miR-125b 3.24 2.22 0
miR-708 3.20 2.14 0.54
miR-25 3.13 2.82 0
miR-495 3.03 3.46 0
miR-675 2.98 2.95 0
miR-27b 2.96 3.11 0
miR-337-3p 2.86 1.96 0.54
miR-24-2-5p 2.83 1.47 2.63
miR-939 2.81 1.23 3.92
miR-199b 2.80 1.86 0.95
miR-30d 2.72 2.28 0
miR-543 2.68 2.94 0
miR-889 2.67 2.21 0.54
miR-29c 2.60 2.78 0
miR-148a 2.52 2.37 0
miR-26b 2.51 2.34 0
miR-1180 2.42 2.64 0
miR-296 2.41 2.12 0.54
miR-99b 2.38 4.19 0
miR-27a 2.32 2.55 0
miR-625* 2.32 1.56 2.63
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cartilage to date and is known to be highly expressed and almost
specific to cartilaginous tissues. Miyaki et al reported higher levels
of miR-140 expression in proliferating chondrocytes of mature
(post-natal day 10) murine growth plates compared to hypertro-
phic chondrocytes [27]. In our system, we did not detect
significant differences in expression of miR-140 between precur-
sor, differentiated proliferating and hypertrophic chondrocytes.
This discrepancy may be explained by species difference as well as
the stage of growth plate development analyzed (mature murine vs
human embryonic growth plates). These findings may also suggest
that miR-140 expression patterns change as the cartilage growth
plate matures. Also, Miyaki et al detected the larger primary
precursor form of miR-140 (pri-miR-140) in murine growth plate
sections by in situ hybridization that includes both 5p and 3p
strand; different expression patterns may be obtained by
specifically detecting either the mature 5p or 3p strand in vivo.
We also detected expression of miR-140-3p in all three regions of
developing cartilage, albeit at lower levels than miR-140-5p (,18-
22 fold less depending on the cartilage region; results not shown).
However, two studies have reported higher expression of the 3p
strand in mature rat or neonatal murine epiphyseal growth plate
cartilage [24,63]. This suggests that both the 5p and 3p strands of
miR-140 are functional and that their ratio levels could change
depending on developmental time point. It will also be interesting
to determine expression levels of miR-140-3p and -5p in
osteoarthritic cartilage given a recent report describing regulation
of miR-140-3p by the inflammatory cytokine, TNF-a, in airway
smooth muscle cells [64]. Therefore, in addition to a role for miR-
140 in regulating development and homeostasis of cartilage tissue
[27,28] additional functions (potentially distinct functions for the
5p and 3p strands) may exist in an inflammatory environment as
Table 5. Enriched pathways of predicted genes
targeted by differentially expressed miRNAs (PC.DC).
Developmental Pathways p-value
IGF-1 receptor signaling 4.364E-11
TGF-b receptor signaling 4.495E-08
BMP signaling 5.546E-07
FGF receptor signaling 9.964E-07
Role of activin A in cell differentiation and proliferation 8.405E-06
FGF family signaling 5.546E-05
VEGF family signaling 5.844E-05
doi:10.1371/journal.pone.0075012.t005
Table 6. Enriched pathways of predicted genes
targeted by differentially expressed miRNAs (PC,DC).
Developmental Pathways p-value
IGF-1 receptor signaling 1.783E-05
Hedgehog signaling 5.214E-04
WNT5a signaling 5.867E-04
WNT signaling (general) 1.122E-03
Hedgehog and PTH signaling in bone and cartilage development 1.152E-03
Role of activin A in cell differentiation and proliferation 1.192E-02
doi:10.1371/journal.pone.0075012.t006
Table 3. Cont.
PC compared to HYP
PC.HYP PC,HYP
miR-199a 2.28 1.89 0.95
miR-369-3p 2.25 1.20 3.92
miR-380-5p 2.24 1.51 2.63
miR-1244 2.20 1.39 2.63
miR-214 2.15 2.61 0
miR-433 2.14 2.61 0
miR-99b* 2.14 2.69 0
miR-301b 2.11 1.86 0.95
miR-106b 2.09 2.12 0.54
miR-769-5p 2.00 2.72 0
Fold change (f.c.) expression of miRNAs between cells of PC and HYP regions
are shown. The score (d) and q-values for each differentially-expressed miRNA
are shown based on SAM analysis (FDR#5%; n = 8–9).
doi:10.1371/journal.pone.0075012.t003
Table 4. Differentially-expressed miRNAs between
differentiated chondrocytes (DC) and hypertrophic
chondrocytes (HYP) from gestational day 54–56
human embryonic cartilage tissue.
DC compared to HYP
DC.HYP DC,HYP
miRNA f.c. Score q-value miRNA f.c. Score q-value
miR-335* 9.23 7.97 0 miR-181a-1 -6.17 -3.16 0
miR-483-3p 4.53 4.55 0 miR-181a-2 -3.79 -3.27 0
miR-335 3.79 3.96 0 miR-17 -3.16 -4.07 0
miR-301 2.94 2.86 0 miR-1290 -2.72 -2.44 4.39
miR-320b 2.74 1.64 4.39 miR-20a -2.20 -2.47 4.39
miR-758 2.72 3.08 0 miR-1260 -2.01 -2.48 4.39
miR-125a-5p 2.71 3.25 0
miR-16 2.69 2.57 0
miR-380-5p 2.60 3.34 0
miR-660 2.59 2.65 0
miR-532-5p 2.55 1.80 2.41
miR-196b 2.30 2.75 0
miR-532-3p 2.26 3.54 0
miR-130a 2.11 1.89 2.41
miR-184 2.06 2.05 2.41
miR-542-3p 2.06 1.99 2.41
miR-93* 2.05 3.60 0
miR-1244 2.03 2.02 2.41
miR-224 2.00 2.18 2.41
miR-495 2.00 3.31 0
Fold change (f.c.) expression of miRNAs between cells of DC and HYP regions
are shown. The score (d) and q-values for each differentially-expressed miRNA
are shown based on SAM analysis (FDR#5%; n = 8–9).
doi:10.1371/journal.pone.0075012.t004
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found in osteoarthritic cartilage.
Other highly-expressed miRNAs include those of the miR-
17,92 cluster (miR-17, miR-20a, miR-19b, miR-92a) (Table 1).
Interestingly, germline deletion of this cluster has been linked to
human skeletal and growth defects [18]. miRs-18a and 19a from
this cluster were also expressed in human embryonic chondro-
cytes, but not as highly as the other miRNAs in the cluster. Also,
our studies showed that miR-17 and miR-20a were found to be
significantly more highly-expressed in hypertrophic chondrocytes
compared to both precursor and differentiated chondrocytes
(Tables 3 and 4). These expression patterns suggest that
miRNAs in this cluster may be distinctly regulated and that some
of them (i.e. miRs-17 and 20a) may function to regulate terminal
hypertrophic chondrocyte differentiation or endochondral ossifi-
cation. In other systems, the miR-17,92 cluster has been shown
to regulate components of the TGF-b pathway as well as
angiogenesis [65–70]. Future studies will be required to determine
if, in the context of chondrogenesis, miRNAs in this cluster affects
TGF-b signaling and endochondral ossification processes. Inter-
estingly, within the top 30 most abundant miRNAs expressed in all
regions of developing human cartilage was miR-206, which is
known to be a muscle-specific miRNA [71] (Table 1). This
miRNA was also found to be highly expressed in mouse cartilage
[24] and muscle-specific gene expression has been reported
recently in murine articular cartilage within the context of ageing
and OA [72,73]. The potential role of these muscle-related
miRNAs and genes in cartilage development and disease may be
worth pursuing. The miRNA OpenArrayH screen also identified
high expression of miR-376a in chondrocytes throughout the
human developing limb. This miRNA is part of a large cluster, two
of which (miR-654/376b) were found to be expressed strongly in
murine embryonic cartilage [74]. Our studies also showed that
miR-127 and miR-409-3p were strongly expressed at all stages of
human embryonic chondrocyte differentiation. Interestingly, these
two miRNAs (in addition to miR-376b) were also identified as
being more highly expressed in chondrocytes from murine
neonatal hind limb cartilage when compared to osteoblasts [24].
We are currently pursuing studies to determine functional roles of
these abundantly-expressed miRNAs in the context of cartilage
biology.
Differentially expressed microRNAs
A number of miRNAs identified in this study as significantly
differentially expressed between precursor, differentiated and
hypertrophic chondrocytes have also been described in other
reports within the context of skeletal development or cartilage
biology. miR-196b expression patterns indicate a potential role in
regulating specific phases of chondrogenesis given that levels were
found to be higher in precursor or differentiated chondrocytes
(Tables 2, 3, 4). In fact, miR-196 sub-types (including both miR-
196a and miR-196b, which are almost identical in sequence but
located on different chromosomes) have been reported to regulate
skeletal patterning in zebrafish, chicken and salamander [75–77].
This patterning role is partly explained by the fact that miRs-
196a/b are located within HOX gene clusters and can regulate
expression of some of these patterning genes [76,78–80]. miRs-
196a/b have also been shown to regulate ERG transcription
factors [81]. This is interesting since ERG is specifically localized to
developing articular cartilage of the joint and functions in
regulating proper cartilage development [82]. Increased expres-
sion of miR-196a has also been shown to decrease proliferation of
adipose-derived stem cells and enhance their osteogenic potential
without affecting adipogenesis [83]. It will be important to
establish how altered expression of miR-196 affects the chondro-
genic potential of precursor stem cells in vitro.
Another miRNA identified as over 2-fold more highly expressed
in PC compared to HYP is miR-433 (Table 3). This miRNA has
been linked to chondrodysplasia in humans since a mutation in the
39UTR of HDAC6 was identified within a miR-433 binding site
[19]. Other differentially-expressed miRNAs found in this study
(miRs-27a, 675, 483) (Tables 2, 3, 4) have been reported in the
context of cartilage and osteoarthritis (OA). miR-27a was found to
be expressed in human OA chondrocytes and to indirectly affect
expression of IGFBP-5 and MMP-13 [84]. Its differential
expression pattern, as seen in our system, suggests a developmental
role in controlling early stage chondrocyte differentiation
(Tables 2–3). In vitro studies showed that miR-675 indirectly
affected levels of COL2A1 in differentiated human articular
chondrocytes [32]. Recently Steck et al reported that expression
of this miRNA was elevated in human OA as was the long non-
coding RNA, H19, which harbors miR-675 [85]. Interestingly,
H19/miR-675 is located within an imprinted domain on human
chromosome 11. H19 is maternally expressed while IGF2 is
paternally-expressed and harbors miR-483 within intron 2. Steck
et al also reported elevated IGF2 levels in OA cartilage while levels
of miR-483 were not described in this study. However, other
studies have reported increased levels of miR-483-5p in OA
cartilage [34,86]. It will be interesting to further dissect how
regulation of chondrocytes by H19/miR-675 and IGF2/miR-483
affects cartilage matrix production and maintenance. In our
studies, we detected miR-483-5p expression in human embryonic
chondrocytes, but only miR-483-3p was found to be differentially-
expressed in precursor and differentiated chondrocytes when
Table 7. Enriched pathways of predicted genes
targeted by differentially expressed miRNAs
(DC.HYP).
Developmental Pathways p-value
TGF-b receptor signaling 4.671E-10
WNT5a signaling 9.408E-09
FGF receptor signaling 1.008E-07
BMP signaling 1.660E-07
Role of activin A in cell differentiation and proliferation 3.126E-07
IGF-1 receptor signaling 2.002E-06
VEGF signaling and activation 5.438E-06
doi:10.1371/journal.pone.0075012.t007
Table 8. Enriched pathways of predicted genes
targeted by differentially expressed miRNAs
(DC,HYP).
Developmental Pathways p-value
TGF-b receptor signaling 1.252E-07
FGF receptor signaling 3.583E-07
WNT5a signaling 2.962E-06
IGF-1 receptor signaling 9.252E-06
Role of IL-8 in angiogenesis 2.076E-05
Role of activin A in cell differentiation and proliferation 2.452E-05
Hedgehog signaling 8.933E-05
doi:10.1371/journal.pone.0075012.t008
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compared to hypertrophic chondrocytes (Tables 3 and 4). Also,
expression levels of the 5p and 3p strands of miR-483 in PC and
DC regions were similar suggesting that both mature strands are
functional in chondrocytes. Whether these 5p and 3p strands have
distinct functions in chondrocytes remains to be determined.
Expression of miR-146a has also been reported in OA
chondrocytes; mechanistically, miR-146a is apparently responsive
to IL-1b signaling and may be involved in pain-related patho-
physiology of OA [38,87,88]. This miRNA was detected in our
screen, but not differentially-expressed between cartilage regions.
However, its homologue, miR-146b, was expressed at higher levels
than miR-146a and was also found to be more highly-expressed in
precursor chondrocytes when compared to differentiated and
hypertrophic chondrocytes in our studies (Tables 2 and 3).
miRs-146a and b differ by 2 nucleotides and are located on
different chromosomes. Therefore, it is possible that these miRNA
homologues are differentially-regulated during chondrogenesis
and carry out distinct functions to control developmental processes
as well as homeostasis in mature tissue. Studies to address this
hypothesis are underway in our laboratory.
Among those miRNAs more highly expressed in differentiated
or hypertrophic chondrocytes when compared to precursor
chondrocytes, it is interesting that two of these, miRs-365 and
222 (Tables 2 and 3), have been postulated to play a mechano-
regulatory role in cartilage [60,89]. miR-365 is clustered with
miR-193b which shows similar expression patterns to miR-365 in
our system (Tables 2 and 3), thus suggesting that these miRNAs
may be co-regulated. Therefore, in addition to a mechano-
regulatory role in mature cartilage tissues, our studies suggest a
potential developmental role for these miRNAs in regulating later
stages of chondrocyte differentiation. Other miRNAs detected in
our screen that are more abundantly-expressed in HYP cells
compared to cells in the DC and PC regions also suggests
functional role(s) in regulating terminal differentiation of chon-
drocytes and/or endochondral ossification processes (e.g. miRs-
181a-1, 181a-2, 17, 1290, 1291, 20a, 1260, 150, 202, 139-5p, 126,
127) (Tables 3 and 4).
Other microRNAs not yet reported in cartilage
miR-335-5p and the less abundant 3p strand (miR-335*)
showed significantly high fold changes in differential expression
patterns in our studies (Tables 2, 3, 4). Although expression
levels of miR-335* were generally lower than miR-335-5p,
detection of this ‘‘minor’’ strand suggests that it may be functional
in the context of cartilage biology. While miR-335* has not been
reported in cartilage until now, one previous study has shown
down-regulation of the miR-335-5p strand in de-differentiated
chondrocytes [89]. Unpublished observations in our laboratory
have shown a sharp decrease in miR-335-5p expression during
TGF-b3 induced chondrocyte differentiation of human MSCs.
These findings suggest a potential role for the 5p strand of miR-
335 in regulating genes to maintain a more progenitor phenotype.
A recent study by Tome et al [90] supports this view since they
found miR-335-5p down-regulation was required to permit MSC
differentiation toward the osteogenic or adipogenic lineage; over-
expression of this miRNA inhibited MSC differentiation. Howev-
er, another study reported opposite effects of miR-335-5p in
regulating osteogenesis [91], but this may be explained by the fact
that cell lines were used here as opposed to primary MSCs. It will
be interesting to determine how modulation of miR-335/335*
expression affects chondrocyte differentiation.
This study is the first to report miR-138 in cartilage and that
higher expression is associated with differentiated and hypertro-
phic chondrocytes when compared to precursor cells (,12 fold
and 17 fold difference, respectively; Tables 2 and 3). These
expression patterns potentially indicate a role in regulating specific
phases of chondrocyte differentiation. Other studies have shown
that over-expression of miR-138 inhibits osteogenic and adipo-
genic differentiation [92,93]. Interestingly, it has also been
demonstrated that miR-138 can promote induced pluripotent
stem cell (iPS) generation via regulation of p53 [94]. This clearly
indicates that miR-138 can control cellular differentiation and
may function through different mechanisms depending on the
tissue microenvironment. It will be important to understand how
this miRNA regulates chondrogenesis and the mechanisms
involved. In addition to miR-335 and miR-138, there are a
number of other differentially-expressed miRNAs identified in the
present study that will be worth pursuing in the context of cartilage
biology; some of these are generally not well-reported in the
literature and their functional roles in normal tissue development
and homeostasis are unknown so far (e.g. miRs- 301, 502, 532,
660, 1244, 1247, 1290, 1291).
Regulation of cellular pathways by microRNAs in
cartilage
miRNA function in cartilage development and homeostasis is
becoming a rapidly-growing area of research [21–23]. This study
has identified many miRNAs worth pursuing for their potential
function in regulating specific phases of chondrocyte differentia-
tion. However, once functional miRNAs have been identified, the
next challenge is to understand the mechanisms by which specific
miRNAs, or sub-groups of miRNAs, control cellular processes.
While many studies report on a specific miRNA that can interact
with and regulate one target gene, this does not reflect the in vivo
situation since miRNAs can potentially target hundreds of genes
(Krek, 2005). Also, the degree of miRNA repression on an
individual target is usually very mild [95–97] and so to exert
significant biological function, miRNAs may regulate multiple
genes within the same pathway as has been shown for the miR-16
family of miRNAs and for miR-17-5p [98,99]. In addition, the
target genes and the pathways involved will be different for a
specific miRNA or group of miRNAs depending on the tissue type
and time point of development, for example [100]. Based on the
differentially-expressed miRNA data presented in this study, we
wanted to investigate (as a first-step approach) potential cellular
pathways that may be regulated by the groups of miRNAs
expressed more highly in progenitor, differentiated or hypertro-
phic chondrocytes. It must be stressed that the bioinformatics
approach taken here has generated preliminary data that will
require further validation once functional activity for these
miRNAs has been confirmed. One attractive approach to confirm
(or disprove) bioinformatics-based target gene data involves
biochemically identifying target genes located within the RNA-
induced silencing complex (RISC) followed by RNA-Seq analysis
[101]; we are currently establishing this methodology in our
laboratory.
For the purpose of this report, we have presented significantly
enriched pathways related only to developmental processes that
are known from in vivo and in vitro data to be important within the
context of chondrogenesis. Other significantly enriched pathways
were identified from our bioinformatics approach (i.e. related to
cell cycle, transcription, apoptosis, cytoskeletal remodeling etc),
but making any associations with other cellular processes at this
stage would be over-interpreting the data presented in this study.
With respect to those developmental pathways identified
(Tables 5, 6, 7, 8), a number of the same pathways were shown
to be significantly enriched for each comparison analyzed (i.e.
pathways related to TGFb, BMP, FGF and IGF signaling). This is
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not surprising since these growth factors are known to be
important in controlling many aspects of cartilage development
and maintenance. Interestingly, the pathway involving activin A
was also enriched for each comparison analyzed. Less is known
about the function of this secreted factor in cartilage biology
although there are reports that this TGF-b family member plays a
role in developing as well as mature cartilage [102–104].
Tables 6, 7 and 8 shows that Hedgehog and Wnt signaling
pathways [105,106] may be regulated by miRNAs found to be
more highly expressed in differentiated or hypertrophic chondro-
cytes. These pathways are particularly prominent in Table 6
suggesting that miRs-138, 365 and 193b (Table 2) play a role in
regulating these pathways to permit proper cartilage formation.
VEGF-related signaling pathways were identified in the PC.DC
and DC.HYP comparisons (Tables 5 and 7). Since VEGF
plays a role during vascular invasion of hypertrophic chondrocytes
to permit endochondral ossification [107], it is possible that
specific miRNAs may function to inhibit these processes in
cartilage regions that are not destined to be invaded by vessels and
replaced by bone. On the other hand, pathway analysis revealed
that miRNAs more highly expressed in hypertrophic chondrocytes
may target the pathway involving IL-8 and angiogenesis (Table 8).
This suggests that miRNAs in hypertrophic chondrocytes may
regulate specific target genes to promote neovascularization and
endochondral bone formation. Overall, these bioinformatics-based
findings have generated some clues to suggest that certain
developmental pathways may be regulated by specific miRNAs
at a precise point in differentiation to control proper limb
formation.
Conclusions
This study has identified differentially-expressed miRNAs at a
defined time point during human cartilage development of the
embryonic limb. These findings should provide insights into
miRNA-driven processes that are necessary to generate the
formation of chondroprogenitor, differentiated or hypertrophic
chondrocytes. Clinically, this work may be important for the
design of miRNA-based tissue engineering strategies to promote
endochondral bone repair or regeneration by enhancing hyper-
trophic differentiation and endochondral ossification processes, for
example. Alternatively, miRNA based strategies to inhibit
hypertrophic chondrocyte differentiation could be beneficial for
generation of permanent articular cartilage tissue. It will also be
interesting to investigate if dysregulation of miRNAs important in
regulating developmental processes can cause skeletal defects such
as osteoarthritis, chondrodysplasias or delayed endochondral
fracture healing.
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